Sensory Basis of Speech Motor Learning

NCT ID: NCT04497428

Last Updated: 2025-12-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

160 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-08-01

Study Completion Date

2025-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

These studies test the hypothesis that sensory areas of the brain participate in the consolidation of speech motor memory by using transcranial magnetic stimulation to suppress activity in somatosensory and auditory cortex following adaptation in order to block retention of learning.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subjects will train using either altered somatosensory feedback or altered auditory feedback (different groups of subjects). Immediately following adaptation, continuous theta burst magnetic stimulation (cTBS) will be applied to either auditory or somatosensory or motor cortex with the goal of blocking consolidation of motor memory. The logic of applying cTBS to both sensory areas is to test the hypothesis that both areas are involved in motor memory consolidation. Subjects leave the laboratory following cTBS and return 24 hours later to assess retention of learning. Learning is assessed as percentage change in speech sounds or movements relative to baseline. Retention is measured on a 0 to 100 scale relative to the end of learning.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Speech Consolidation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adaptation to Altered Sensory Feedback + cTBS to S1

Adaptation to Altered Sensory Feedback + cTBS to S1

Group Type EXPERIMENTAL

Adaptation

Intervention Type BEHAVIORAL

Sensorimotor adaptation in speech

cTBS

Intervention Type OTHER

continuous theta-burst stimulation

Adaptation to Altered Sensory Feedback + cTBS to A1

Adaptation to Altered Sensory Feedback + cTBS to A1

Group Type EXPERIMENTAL

Adaptation

Intervention Type BEHAVIORAL

Sensorimotor adaptation in speech

cTBS

Intervention Type OTHER

continuous theta-burst stimulation

Adaptation to Altered Sensory Feedback + cTBS to M1

Adaptation to Altered Sensory Feedback + cTBS to M1

Group Type EXPERIMENTAL

Adaptation

Intervention Type BEHAVIORAL

Sensorimotor adaptation in speech

cTBS

Intervention Type OTHER

continuous theta-burst stimulation

Adaptation to Altered Sensory Feedback + Sham cTBS

Adaptation to Altered Sensory Feedback + Sham cTBS

Group Type EXPERIMENTAL

Adaptation

Intervention Type BEHAVIORAL

Sensorimotor adaptation in speech

cTBS

Intervention Type OTHER

continuous theta-burst stimulation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Adaptation

Sensorimotor adaptation in speech

Intervention Type BEHAVIORAL

cTBS

continuous theta-burst stimulation

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* right handed adults
* no known physical or neurological abnormalities

Exclusion Criteria

* patients with:
* cardiac pacemaker
* surgical clips or values on the heart
* implants
* metal or metallic fragments in any part of the body
* pregnancy
* claustrophobia
* a personal or family history of epilepsy
* currently taking antipsychotic drugs
* currently taking antidepressant drugs
* currently taking antianxiety drugs
* history of concussion.
Minimum Eligible Age

21 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

McGill University

OTHER

Sponsor Role collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

Sponsor Role collaborator

Yale University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David Ostry

Role: PRINCIPAL_INVESTIGATOR

Haskins Laboratories

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

McGill University

Montreal, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01DC017439

Identifier Type: NIH

Identifier Source: secondary_id

View Link

2000025475

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sonification Embodied Associations
NCT03931278 COMPLETED NA